Thoracic Aortic Aneurysm Clinical Trials
2 recruiting trials for Thoracic Aortic Aneurysm. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Thoracic Aortic Aneurysm clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Pennsylvania (1), Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Behavioral nudge (behavioral, 1 trial), followed by Endovascular exclusion.
Track Thoracic Aortic Aneurysm trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways...
ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"
The ENDOBARC-S post-market clinical follow-up study is undertaken to evaluate the prevention of death related to aortic arch pathologies when treated by branch stent graft systems...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Thoracic Aortic Aneurysm, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Thoracic Aortic Aneurysm, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Thoracic Aortic Aneurysm, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.